HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN
Clinical trials for HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN explained in plain language.
Never miss a new study
Get alerted when new HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN trials appear
Sign up with your email to follow new studies for HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug could save babies from deadly blood disorder in the womb
Disease control Recruiting nowThis study tests a medicine called nipocalimab in pregnant women whose babies are at high risk for severe hemolytic disease (HDFN), a condition where the mother's immune system attacks the baby's red blood cells. The goal is to see if the drug can prevent serious problems like se…
Matched conditions: HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 17, 2026 08:33 UTC
-
New global registry aims to understand risks of fetal anemia from blood type mismatch
Knowledge-focused Recruiting nowThis study is a global registry that will follow about 175 pregnant people who are at risk for hemolytic disease of the fetus and newborn (HDFN), a condition where the mother's and baby's blood types don't match, causing the baby's red blood cells to break down too fast. Research…
Matched conditions: HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN
Sponsor: Janssen Research & Development, LLC • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC